Product correctly added to cart.

discount label
HJC0152 Hydrochloride
View 3D

Biosynth logo

HJC0152 Hydrochloride

CAS: 1420290-99-8

Ref. 3D-VGC29099

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Thursday 23 Jan 2025

Product Information

Name:
HJC0152 Hydrochloride
Description:

HJC0152 is a potent anti-tumor agent that can be used in the treatment of cancers. HJC0152 inhibits tumor growth by inhibiting cellular transformation and the proliferation of cancer cells. It has been shown to have potent antitumor activity in vitro and in vivo, as well as inhibitory effects on hyperproliferative diseases such as bowel disease, autoimmune diseases, and cancer. This drug also inhibits the growth of tumors by targeting epithelial mesenchymal transition (EMT) through inhibition of protein synthesis. HJC0152 has been shown to inhibit EMT by blocking an ATPase enzyme called mitochondrial F1F0-ATP synthase. HJC0152 also targets a number of signaling pathways involved in cancer progression, including PI3K/AKT/mTOR and NF-κB pathways.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
370.19 g/mol
Formula:
C15H13Cl2N3O4·HCl
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-VGC29099 HJC0152 Hydrochloride

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".